1.J Urol. 2000 Nov;164(5):1768-75.
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB.
Departments of Laboratory Medicine and Pathology, Urology, and Biostatistics, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
PMID: 11025767 [PubMed - indexed for MEDLINE]
----------------------------------------------------------------------------------------------------
2.J Urol. 2006 Jul;176(1):44-7.
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.
South Texas Urology and Urologic Oncology, 4499 Medical #218, San Antonio, TX 78229, USA.
PMID: 16753364 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------------------------------------------------
3.Urol Int. 2005;75(3):193-200.
Non-invasive diagnostic tests for bladder cancer: a review of the literature.
Bassi P, De Marco V, De Lisa A, Mancini M, Pinto F, Bertoloni R, Longo F.
Department of Urology, University of Padova Medical School, Padova, Italy.
bassipf@tin.itPMID: 16215303 [PubMed - indexed for MEDLINE]
